{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-032612","form_type":"8-K","ticker":"MNPR","cik":"0001645469","company_name":"Monopar Therapeutics","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.089136+00:00","generated_at":"2026-05-30T08:19:09.581730+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Monopar Therapeutics prices $19.2M public stock offering at $16.25 per share","bullets":["Gross proceeds ~$19.2M from offering of up to 1,181,540 shares at $16.25/share.","Participating investors include Janus Henderson, RA Capital Management, L.P.","Net proceeds to be used for R&D, clinical trials, manufacture, and working capital.","Offering closed October 30, 2024; Rodman & Renshaw acted as placement agent.","Placement agent fee is 7.0% of gross proceeds plus expense reimbursement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-032612","json":"https://secwatch.observer/filing/0001437749-24-032612.json","markdown":"https://secwatch.observer/filing/0001437749-24-032612.md","text":"https://secwatch.observer/filing/0001437749-24-032612.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/0001437749-24-032612-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645469/000143774924032612/mnpr20241029_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:19:09.581730+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}